Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Oct 31, 2023
Q1 FY2024
As of Apr 30, 2023
Q2 FY2024
As of Jul 31, 2023
Q4 FY2023
As of Jan 31, 2023
Q3 FY2023
As of Oct 31, 2022
Q2 FY2023
As of Jul 31, 2022
Q1 FY2023
As of Apr 30, 2022
Q4 FY2022
As of Jan 31, 2022
Q3 FY2022
As of Oct 31, 2021
Q2 FY2022
As of Jun 30, 2021
Q1 FY2022
As of Mar 31, 2021
Q4 FY2021
As of Dec 31, 2020
Q3 FY2021
As of Sep 30, 2020
Q2 FY2021
As of Jun 30, 2020
Q1 FY2021
As of Mar 31, 2020
Q4 FY2020
As of Dec 31, 2019
Q3 FY2020
As of Sep 30, 2019
Assets
Current assets
Cash
Cash and cash equivalents
Accounts Receivable
Related Party
Total accounts Receivable
Unbilled receivable
Related party receivables
Accounts, related party and loans receivable
Inventory
Deferred costs
Prepaid warranty
Prepaid expenses and other current assets
Prepaid expenses
Other current assets
Total current assets
Deferred tax asset
Deferred tax asset
Marketable securities held in Trust Account
Deferred costs
Property and equipment, net
Prepaid warranty
Operating lease right-of-use assets, net
Deposits and other assets
Total assets
Liabilities and stockholders' equity
Current liabilities:
Accounts payable and accrued expenses
Income taxes payable
Accounts payable
Accrued expenses
Deferred revenue
Related party notes payable
Convertible notes payable
Conversion features on convertible notes payable
Deferred rent
Short-term PPP loan
Income tax payable
Other current liabilities
Total current liabilities
Warrant liabilities
Deferred underwriting fee payable
Deferred revenue
Deferred rent
Warrants
Long-term PPP loan
Other long-term liabilities
Total liabilities not subject to compromise
Liabilities subject to compromise (Note 12)
Total liabilities
Class A common stock subject to possible redemption, 13,401,775 and 13,888,079 shares at redemption value as of June 30, 2021 and December 31, 2020, respectively
Stockholders' equity
Preferred stock, $0.0001 par value; 100,000,000 shares authorized; none issued or outstanding
Common stock; $0.0001 par value; 500,000 shares authorized; 121,507 and 111,466 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively
Common Class A
Class B Common Stock
Total common stock; $0.0001 par value; 500,000 shares authorized; 121,507 and 111,466 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively
Class B convertible common stock, $0.0001 par value; 10,000,000 shares authorized; 4,312,500 shares issued and outstanding as of June 30, 2021 and December 31, 2020
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Subscription notes receivable
Stockholders' (deficit) equity
Common Class A
Class B Common Stock
Total stockholders' (deficit) equity
Total liabilities and stockholders' (deficit) equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support